Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

CCBIO Associate Researcher Agnete S.T. Engelsen has just completed a one-year certificate program at Harvard Medical School (HMS), the High-Impact Cancer Research (HICR): Cancer, Biology and Therapeutics Program. Engelsen was the first attendee from Norway in this diverse group of highly motivated new and seasoned researchers from 42 countries, all around the world.
CCBIO hosted the 4th Annual Scandinavian Seminar on Translational Pathology at Solstrand Hotel, Os (Bergen), with 78 dedicated participants from Norway, Sweden and Finland.
October 15th, Professor Bruce R. Zetter from Harvard Medical School and Boston Children’s Hospital was appointed as Honorary Doctor at the University of Bergen, Faculty of Medicine. The day before, October 14th, he gave his honorary doctor lecture, on the topic "RNA as a tool for cancer therapy".
Det medisinske fakultets nye æresdoktor Bruce R. Zetter sier at utnevnelsen vil føre til et enda sterkere bånd mellom Harvard Medical School og Universitetet i Bergen.
Iceland’s dramatic landscape served as backdrop for generating ideas and action plans for new collaborations between the University of Bergen/CCBIO and Harvard Medical School/Vascular Biology Program in a meeting August 29th to September 3rd.
The University of Bergen is appointing 10 new Honorary Doctors, one of which is Harvard Professor Bruce Zetter, very well known to the CCBIO family, both as advisor in the CCBIO Scientific Advisory Board, and through the CCBIO-VBP INTPART collaboration.
The collaboration project for education and research in oral pathology between Norway, Moldova, Belarus and Armenia is an important internationalization project financed by DIKU through the Eurasia program. Within this project, UiB/CCBIO is currently hosting a master student, Olga Golburean, a graduated dental hygienist who is taking her master degree in global health with Professor Dana Costea... Read more
This summer, CCBIO sent their second batch of students to be Boston summer interns in the CCBIO/Harvard INTPART collaboration. Read the full report from Hanna Dillekås, PhD candidate in Oddbjørn Straume’s group, Ridhima Das, PhD candidate in Dana Costea’s group, and Amalie Fagerli Tegnander, medical student affiliated to Lars A. Akslen's group, in Elisabeth Wik’s project.
Congratulations to CCBIO's Elisabeth Wik for a very well deserved Faculty Internationalization Award! The prize was presented at the Faculty Day, June 13th 2019.
On May 23 and 24, 2019, the world's leading fibrosis and cancer researchers met in Bergen at an international fibrosis conference on the topic "New tools to study the fibrotic stroma".
The CCBIO Annual Report 2018 is now available!
World leading cancer experts met at Solstrand: International top notch cancer researchers met at Solstrand to present their work at CCBIO's annual symposium.
Verdensledende kreftforskere møttes på Solstrand for å presentere sin forskning under CCBIOs årlige symposium.
In February, the first CCBIO INTPART long course – CCBIO907 Cancer-Related Vascular Biology – was completed with the final of three course weeks. Assistant Professors Diane Bielenberg, Vascular Biology Program, Boston Children ‘s Hospital, and Magali Saint-Geniez, Schepens Eye Research Institute of Mass. Eye and Ear, Department of Ophthalmology, Harvard Medical School, lectured and tutored the... Read more
The University of Bergen has just implemented the Hyperion Imaging System, next generation immunohistochemistry where researchers can explore tissue biology with 35 antibodies simultaneously. This instrument is the only of its kind in Northern Europe, and is open for booking for all researchers on equal terms.
The Research Council of Norway has announced that 11 out of 87 received applications have been selected for funding in their programme called "High-quality and Reliable Diagnostics, Treatment and Rehabilitation (BEHANDLING)”. The project “Enhanced cryoimmunotherapy against urogenital cancers” by project leader Karl-Henning Kalland, CCBIO PI, was among the 11 selected projects and was one of... Read more
The Norwegian Research Council and other European research councils are about to make a radical alteration of the scientific publishing model by forcing Open Access for all scientific work. The scheme is called Plan S. 27 Norwegian research leaders, including CCBIO Director Lars A. Akslen, suggest changes to improve the European Plan S Open Access scheme.
CCBIO PhD Candidate Hilde Engerud in the Gynecologic Cancer Research Group was awarded with Best Presentation at the annual meeting of the Norwegian Society for Gynecology and Obstetrics this fall, October 25 and 26 2018.

Pages